Holger was Chief Financial Officer at Boule Diagnostics, and Chief Financial Officer at Oncopeptides. Holger Lembrér joined Enzymatica in 2025.
Holger Lembrér is currently
Create your alert
to follow the career of Holger Lembrér.
In 2008, Holger Lembrér completed a Master in Accounting and Financial Management at Uppsala University.
They have also studied at Uppsala University :
Find more alumni from Uppsala University
Do you need to know more about Holger Lembrér? More results.
Report an error
Update the org chart details of Holger Lembrér.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.